annual working capital:
$707.66M+$307.09M(+76.66%)Summary
- As of today (July 4, 2025), CLDX annual working capital is $707.66 million, with the most recent change of +$307.09 million (+76.66%) on December 31, 2024.
- During the last 3 years, CLDX annual working capital has risen by +$313.35 million (+79.47%).
- CLDX annual working capital is now at all-time high.
Performance
CLDX Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$661.74M-$45.92M(-6.49%)Summary
- As of today (July 4, 2025), CLDX quarterly working capital is $661.74 million, with the most recent change of -$45.92 million (-6.49%) on March 31, 2025.
- Over the past year, CLDX quarterly working capital has dropped by -$147.29 million (-18.21%).
- CLDX quarterly working capital is now -18.21% below its all-time high of $809.03 million, reached on March 31, 2024.
Performance
CLDX quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
CLDX Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +76.7% | -18.2% |
| 3 y3 years | +79.5% | +75.9% |
| 5 y5 years | +1185.4% | +1371.0% |
CLDX Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +136.6% | -18.2% | +203.4% |
| 5 y | 5-year | at high | +1185.4% | -18.2% | +332.2% |
| alltime | all time | at high | >+9999.0% | -18.2% | >+9999.0% |
CLDX Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $661.74M(-6.5%) |
| Dec 2024 | $707.66M(+76.7%) | $707.66M(-5.2%) |
| Sep 2024 | - | $746.75M(-4.8%) |
| Jun 2024 | - | $784.32M(-3.1%) |
| Mar 2024 | - | $809.03M(+102.0%) |
| Dec 2023 | $400.57M(+33.9%) | $400.57M(+83.7%) |
| Sep 2023 | - | $218.10M(-12.5%) |
| Jun 2023 | - | $249.17M(-9.2%) |
| Mar 2023 | - | $274.38M(-8.3%) |
| Dec 2022 | $299.08M(-24.2%) | $299.08M(-6.0%) |
| Sep 2022 | - | $318.31M(-5.8%) |
| Jun 2022 | - | $338.03M(-10.1%) |
| Mar 2022 | - | $376.14M(-4.6%) |
| Dec 2021 | $394.31M(+114.7%) | $394.31M(-4.4%) |
| Sep 2021 | - | $412.38M(+169.3%) |
| Jun 2021 | - | $153.12M(-6.9%) |
| Mar 2021 | - | $164.52M(-10.4%) |
| Dec 2020 | $183.64M(+233.6%) | $183.64M(-3.7%) |
| Sep 2020 | - | $190.72M(-3.7%) |
| Jun 2020 | - | $198.15M(+340.5%) |
| Mar 2020 | - | $44.99M(-18.3%) |
| Dec 2019 | $55.05M(-36.3%) | $55.05M(-12.9%) |
| Sep 2019 | - | $63.22M(-13.2%) |
| Jun 2019 | - | $72.86M(-5.2%) |
| Mar 2019 | - | $76.86M(-11.1%) |
| Dec 2018 | $86.48M(-26.1%) | $86.48M(-8.1%) |
| Sep 2018 | - | $94.12M(-6.2%) |
| Jun 2018 | - | $100.30M(-6.2%) |
| Mar 2018 | - | $106.96M(-8.6%) |
| Dec 2017 | $117.02M(-27.0%) | $117.02M(-4.4%) |
| Sep 2017 | - | $122.40M(-6.8%) |
| Jun 2017 | - | $131.26M(-10.4%) |
| Mar 2017 | - | $146.44M(-8.7%) |
| Dec 2016 | $160.35M(-39.4%) | $160.35M(-16.1%) |
| Sep 2016 | - | $191.08M(-8.5%) |
| Jun 2016 | - | $208.78M(-11.4%) |
| Mar 2016 | - | $235.65M(-11.0%) |
| Dec 2015 | $264.70M(+46.7%) | $264.70M(-7.3%) |
| Sep 2015 | - | $285.62M(-8.7%) |
| Jun 2015 | - | $312.85M(-8.8%) |
| Mar 2015 | - | $342.98M(+90.0%) |
| Dec 2014 | $180.49M(-36.6%) | $180.49M(-13.3%) |
| Sep 2014 | - | $208.21M(-11.2%) |
| Jun 2014 | - | $234.40M(-8.9%) |
| Mar 2014 | - | $257.31M(-9.7%) |
| Dec 2013 | $284.84M(+322.4%) | $284.84M(+131.3%) |
| Sep 2013 | - | $123.15M(-14.4%) |
| Jun 2013 | - | $143.93M(-13.4%) |
| Mar 2013 | - | $166.12M(+146.4%) |
| Dec 2012 | $67.43M(+67.0%) | $67.43M(+5.9%) |
| Sep 2012 | - | $63.68M(-6.1%) |
| Jun 2012 | - | $67.82M(-17.0%) |
| Mar 2012 | - | $81.69M(+102.3%) |
| Dec 2011 | $40.39M(-5.5%) | $40.39M(-24.7%) |
| Sep 2011 | - | $53.60M(-14.8%) |
| Jun 2011 | - | $62.88M(+68.5%) |
| Mar 2011 | - | $37.31M(-12.7%) |
| Dec 2010 | $42.74M(-38.6%) | $42.74M(+19.0%) |
| Sep 2010 | - | $35.92M(-19.4%) |
| Jun 2010 | - | $44.54M(-16.7%) |
| Mar 2010 | - | $53.46M(-23.2%) |
| Dec 2009 | $69.57M(+111.0%) | $69.57M(+400.4%) |
| Sep 2009 | - | $13.90M(-32.7%) |
| Jun 2009 | - | $20.65M(-25.7%) |
| Mar 2009 | - | $27.79M(-15.7%) |
| Dec 2008 | $32.98M(-843.0%) | $32.98M(-11.2%) |
| Sep 2008 | - | $37.14M(-24.0%) |
| Jun 2008 | - | $48.87M(+336.4%) |
| Mar 2008 | - | $11.20M(-352.3%) |
| Dec 2007 | -$4.44M(-113.7%) | -$4.44M(-135.2%) |
| Sep 2007 | - | $12.62M(-33.1%) |
| Jun 2007 | - | $18.86M(-20.5%) |
| Mar 2007 | - | $23.72M(-26.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $32.32M(+54.5%) | $32.32M(-19.1%) |
| Sep 2006 | - | $39.93M(-17.5%) |
| Jun 2006 | - | $48.40M(-11.6%) |
| Mar 2006 | - | $54.74M(+161.7%) |
| Dec 2005 | $20.91M(-28.5%) | $20.91M(-16.4%) |
| Sep 2005 | - | $25.01M(-15.3%) |
| Jun 2005 | - | $29.51M(+21.5%) |
| Mar 2005 | - | $24.30M(-16.9%) |
| Dec 2004 | $29.25M(+54.6%) | $29.25M(-10.8%) |
| Sep 2004 | - | $32.80M(-11.0%) |
| Jun 2004 | - | $36.87M(-9.0%) |
| Mar 2004 | - | $40.50M(+114.0%) |
| Dec 2003 | $18.92M(-15.6%) | $18.92M(-12.5%) |
| Sep 2003 | - | $21.62M(+52.5%) |
| Jun 2003 | - | $14.17M(-17.3%) |
| Mar 2003 | - | $17.13M(-23.6%) |
| Dec 2002 | $22.43M(-40.7%) | $22.43M(-12.1%) |
| Sep 2002 | - | $25.52M(-6.7%) |
| Jun 2002 | - | $27.36M(-16.4%) |
| Mar 2002 | - | $32.74M(-13.4%) |
| Dec 2001 | $37.82M(-18.5%) | $37.82M(+22.2%) |
| Sep 2001 | - | $30.95M(-16.9%) |
| Jun 2001 | - | $37.24M(-13.0%) |
| Mar 2001 | - | $42.79M(-7.8%) |
| Dec 2000 | $46.41M(+277.6%) | $46.41M(-0.1%) |
| Sep 2000 | - | $46.47M(+210.5%) |
| Jun 2000 | - | $14.97M(-13.9%) |
| Mar 2000 | - | $17.39M(+41.5%) |
| Dec 1999 | $12.29M(-0.1%) | $12.29M(-21.2%) |
| Sep 1999 | - | $15.60M(+102.6%) |
| Jun 1999 | - | $7.70M(-20.6%) |
| Mar 1999 | - | $9.70M(-21.1%) |
| Dec 1998 | $12.30M(+167.4%) | $12.30M(-8.9%) |
| Sep 1998 | - | $13.50M(+181.3%) |
| Jun 1998 | - | $4.80M(-30.4%) |
| Mar 1998 | - | $6.90M(+50.0%) |
| Dec 1997 | $4.60M(-60.7%) | $4.60M(-31.3%) |
| Sep 1997 | - | $6.70M(-30.2%) |
| Jun 1997 | - | $9.60M(-14.3%) |
| Mar 1997 | - | $11.20M(-4.3%) |
| Dec 1996 | $11.70M(+4.5%) | $11.70M(-16.4%) |
| Sep 1996 | - | $14.00M(+133.3%) |
| Jun 1996 | - | $6.00M(-27.7%) |
| Mar 1996 | - | $8.30M(-25.9%) |
| Dec 1995 | $11.20M(-25.8%) | $11.20M(+89.8%) |
| Sep 1995 | - | $5.90M(-40.4%) |
| Jun 1995 | - | $9.90M(-22.0%) |
| Mar 1995 | - | $12.70M(-15.9%) |
| Dec 1994 | $15.10M(-42.1%) | $15.10M(-12.7%) |
| Sep 1994 | - | $17.30M(-13.9%) |
| Jun 1994 | - | $20.10M(-14.5%) |
| Mar 1994 | - | $23.50M(-10.0%) |
| Dec 1993 | $26.10M(+55.4%) | $26.10M(+143.9%) |
| Sep 1993 | - | $10.70M(-18.9%) |
| Jun 1993 | - | $13.20M(-12.0%) |
| Mar 1993 | - | $15.00M(-17.6%) |
| Dec 1992 | $16.80M(-19.2%) | - |
| Oct 1992 | - | $18.20M(-7.1%) |
| Jul 1992 | - | $19.60M(-5.8%) |
| Apr 1992 | - | $20.80M(-7.6%) |
| Apr 1992 | $20.80M(+166.7%) | - |
| Jan 1992 | - | $22.50M(-2.2%) |
| Oct 1991 | - | $23.00M(-5.3%) |
| Jul 1991 | - | $24.30M(+211.5%) |
| Apr 1991 | $7.80M(-23.5%) | $7.80M(-1.3%) |
| Jan 1991 | - | $7.90M(-9.2%) |
| Oct 1990 | - | $8.70M(-6.5%) |
| Jul 1990 | - | $9.30M(-8.8%) |
| Apr 1990 | $10.20M(+24.4%) | $10.20M(+39.7%) |
| Jan 1990 | - | $7.30M(-11.0%) |
| Apr 1989 | $8.20M(-20.4%) | $8.20M(-20.4%) |
| Apr 1988 | $10.30M(-16.3%) | $10.30M(-16.3%) |
| Apr 1987 | $12.30M(+434.8%) | $12.30M(+434.8%) |
| Apr 1986 | $2.30M | $2.30M |
FAQ
- What is Celldex Therapeutics annual working capital?
- What is the all time high annual working capital for Celldex Therapeutics?
- What is Celldex Therapeutics annual working capital year-on-year change?
- What is Celldex Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly working capital year-on-year change?
What is Celldex Therapeutics annual working capital?
The current annual working capital of CLDX is $707.66M
What is the all time high annual working capital for Celldex Therapeutics?
Celldex Therapeutics all-time high annual working capital is $707.66M
What is Celldex Therapeutics annual working capital year-on-year change?
Over the past year, CLDX annual working capital has changed by +$307.09M (+76.66%)
What is Celldex Therapeutics quarterly working capital?
The current quarterly working capital of CLDX is $661.74M
What is the all time high quarterly working capital for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly working capital is $809.03M
What is Celldex Therapeutics quarterly working capital year-on-year change?
Over the past year, CLDX quarterly working capital has changed by -$147.29M (-18.21%)